DSM-Firmenich stock after-hours at EUR 97.58: minus 0.73 percent versus prior close
Published on 09/30/2026 at 18:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
DSM-Firmenich stock was at EUR 97.58 after-hours at 6:09 p.m. CEST on September 30, 2026, according to Lang & Schwarz. The price was down 0.73 percent versus the prior Lang & Schwarz close of EUR 98.30.
Trading day at Lang & Schwarz
The bid was EUR 97.24 and the ask was EUR 97.92. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of DSM-Firmenich stock.
Share repurchases and new biologics portfolio
In a September 29, 2026 release, dsm-firmenich said that 313,835 ordinary shares had been repurchased on its behalf between September 21 and September 25 at an average price of EUR 96.45, for a total of EUR 30.3 million. The company said 6,976,047 shares had been repurchased under the program to that point, at an average price of EUR 74.68 and a total consideration of EUR 520.9 million. The EUR 500 million capital-reduction portion was intended to be completed by the end of the third quarter.
Also on September 29, 2026, the company announced the launch of Biond, a portfolio of pharmaceutical-grade vitamins for biopharmaceutical applications. According to dsm-firmenich, the offering is available globally and exclusively through Brenntag Pharma’s BYPHAR biopharma product portfolio.
